CW November 2005
Volume 14Issue Number 11 November 2005 ISSN 10593802 Inhibitor for Growth Factor Receptor Improves Survival of Metastatic Colorectal Cancer PatientsIn a phase III trial, metastatic colorectal cancer patients who had failed standard chemotherapy responded very well to the humanized monoclonal antibody panitumumab.
Go to Previous Page Go to Next Page Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW November 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
